EANS-News: AGENNIX AG Appoints New Vice President of Clinical Development
Dr. Steven Simonson Hired to Lead Talactoferrin Sepsis Development Program Further inquiry note: Agennix AG Barbara Mueller Manager, Investor Relations & Corporate Communications Tel.: +49 89 8565-2693 ir@agennix.com In the USA: Laurie Doyle Senior Director, Investor Relations & Corporate Communications Tel.: 609-524-5884 laurie.doyle@agennix.com Additional media ...